OBJECTIVE: Major depressive disorder is associated with an increased risk of mortality and aging-related diseases. The authors examined whether major depression is associated with higher epigenetic aging in blood as measured by DNA methylation (DNAm) patterns, whether clinical characteristics of major depression have a further impact on these patterns, and whether the findings replicate in brain tissue. METHOD: DNAm age was estimated using all methylation sites in blood of 811 depressed patients and 319 control subjects with no lifetime psychiatric disorders and low depressive symptoms from the Netherlands Study of Depression and Anxiety. The residuals of the DNAm age estimates regressed on chronological age were calculated to indicate epigenetic aging. Major depression diagnosis and clinical characteristics were assessed with questionnaires and psychiatric interviews. Analyses were adjusted for sociodemographic characteristics, lifestyle, and health status. Postmortem brain samples of 74 depressed patients and 64 control subjects were used for replication. Pathway enrichment analysis was conducted using ConsensusPathDB to gain insight into the biological processes underlying epigenetic aging in blood and brain. RESULTS: Significantly higher epigenetic aging was observed in patients with major depression compared with control subjects (Cohen's d=0.18), with a significant dose effect with increasing symptom severity in the overall sample. In the depression group, epigenetic aging was positively and significantly associated with childhood trauma score. The case-control difference was replicated in an independent data set of postmortem brain samples. The top significantly enriched Gene Ontology terms included neuronal processes. CONCLUSIONS: As compared with control subjects, patients with major depression exhibited higher epigenetic aging in blood and brain tissue, suggesting that they are biologically older than their corresponding chronological age. This effect was even more profound in the presence of childhood trauma.
OBJECTIVE: Major depressive disorder is associated with an increased risk of mortality and aging-related diseases. The authors examined whether major depression is associated with higher epigenetic aging in blood as measured by DNA methylation (DNAm) patterns, whether clinical characteristics of major depression have a further impact on these patterns, and whether the findings replicate in brain tissue. METHOD: DNAm age was estimated using all methylation sites in blood of 811 depressedpatients and 319 control subjects with no lifetime psychiatric disorders and low depressive symptoms from the Netherlands Study of Depression and Anxiety. The residuals of the DNAm age estimates regressed on chronological age were calculated to indicate epigenetic aging. Major depression diagnosis and clinical characteristics were assessed with questionnaires and psychiatric interviews. Analyses were adjusted for sociodemographic characteristics, lifestyle, and health status. Postmortem brain samples of 74 depressedpatients and 64 control subjects were used for replication. Pathway enrichment analysis was conducted using ConsensusPathDB to gain insight into the biological processes underlying epigenetic aging in blood and brain. RESULTS: Significantly higher epigenetic aging was observed in patients with major depression compared with control subjects (Cohen's d=0.18), with a significant dose effect with increasing symptom severity in the overall sample. In the depression group, epigenetic aging was positively and significantly associated with childhood trauma score. The case-control difference was replicated in an independent data set of postmortem brain samples. The top significantly enriched Gene Ontology terms included neuronal processes. CONCLUSIONS: As compared with control subjects, patients with major depression exhibited higher epigenetic aging in blood and brain tissue, suggesting that they are biologically older than their corresponding chronological age. This effect was even more profound in the presence of childhood trauma.
Authors: Andrey A Shabalin; Mohammad W Hattab; Shaunna L Clark; Robin F Chan; Gaurav Kumar; Karolina A Aberg; Edwin J C G van den Oord Journal: Bioinformatics Date: 2018-07-01 Impact factor: 6.937
Authors: Brenda W J H Penninx; Aartjan T F Beekman; Johannes H Smit; Frans G Zitman; Willem A Nolen; Philip Spinhoven; Pim Cuijpers; Peter J De Jong; Harm W J Van Marwijk; Willem J J Assendelft; Klaas Van Der Meer; Peter Verhaak; Michel Wensing; Ron De Graaf; Witte J Hoogendijk; Johan Ormel; Richard Van Dyck Journal: Int J Methods Psychiatr Res Date: 2008 Impact factor: 4.035
Authors: Dorret I Boomsma; Gonneke Willemsen; Patrick F Sullivan; Peter Heutink; Piet Meijer; David Sondervan; Cornelis Kluft; Guus Smit; Willem A Nolen; Frans G Zitman; Johannes H Smit; Witte J Hoogendijk; Richard van Dyck; Eco J C de Geus; Brenda W J H Penninx Journal: Eur J Hum Genet Date: 2008-01-16 Impact factor: 4.246
Authors: Riccardo E Marioni; Sonia Shah; Allan F McRae; Stuart J Ritchie; Graciela Muniz-Terrera; Sarah E Harris; Jude Gibson; Paul Redmond; Simon R Cox; Alison Pattie; Janie Corley; Adele Taylor; Lee Murphy; John M Starr; Steve Horvath; Peter M Visscher; Naomi R Wray; Ian J Deary Journal: Int J Epidemiol Date: 2015-01-22 Impact factor: 7.196
Authors: Steve Horvath; Paolo Garagnani; Maria Giulia Bacalini; Chiara Pirazzini; Stefano Salvioli; Davide Gentilini; Anna Maria Di Blasio; Cristina Giuliani; Spencer Tung; Harry V Vinters; Claudio Franceschi Journal: Aging Cell Date: 2015-02-09 Impact factor: 9.304
Authors: Joanne Voisey; Bruce R Lawford; C Phillip Morris; Leesa F Wockner; Ernest P Noble; Ross McD Young; Divya Mehta Journal: NPJ Schizophr Date: 2017-09-04
Authors: Anthony S Zannas; Janine Arloth; Tania Carrillo-Roa; Stella Iurato; Simone Röh; Kerry J Ressler; Charles B Nemeroff; Alicia K Smith; Bekh Bradley; Christine Heim; Andreas Menke; Jennifer F Lange; Tanja Brückl; Marcus Ising; Naomi R Wray; Angelika Erhardt; Elisabeth B Binder; Divya Mehta Journal: Genome Biol Date: 2015-12-17 Impact factor: 13.583
Authors: Laura K M Han; Josine E Verhoeven; Audrey R Tyrka; Brenda W J H Penninx; Owen M Wolkowitz; Kristoffer N T Månsson; Daniel Lindqvist; Marco P Boks; Dóra Révész; Synthia H Mellon; Martin Picard Journal: Psychoneuroendocrinology Date: 2019-04-05 Impact factor: 4.905
Authors: May A Beydoun; Sharmin Hossain; Kumaraswamy Naidu Chitrala; Salman M Tajuddin; Hind A Beydoun; Michele K Evans; Alan B Zonderman Journal: J Affect Disord Date: 2019-06-30 Impact factor: 4.839
Authors: Sierra E Carter; Mei Ling Ong; Ronald L Simons; Frederick X Gibbons; Man Kit Lei; Steven R H Beach Journal: Health Psychol Date: 2019-07-25 Impact factor: 4.267
Authors: Erika J Wolf; Filomene G Morrison; Danielle R Sullivan; Mark W Logue; Rachel E Guetta; Annjanette Stone; Steven A Schichman; Regina E McGlinchey; William P Milberg; Mark W Miller Journal: Brain Behav Immun Date: 2019-03-11 Impact factor: 7.217
Authors: Joseph P Allen; Joshua S Danoff; Meghan A Costello; Gabrielle L Hunt; Amanda F Hellwig; Kathleen M Krol; Simon G Gregory; Stephanie N Giamberardino; Karen Sugden; Jessica J Connelly Journal: Drug Alcohol Depend Date: 2022-02-17 Impact factor: 4.492
Authors: Natalie C Benda; George S Alexopoulos; Patricia Marino; Jo Anne Sirey; Dimitris Kiosses; Jessica S Ancker Journal: AMIA Annu Symp Proc Date: 2021-01-25
Authors: Erika J Wolf; Ci-Di Chen; Xiang Zhao; Zhenwei Zhou; Filomene G Morrison; Nikolaos P Daskalakis; Annjanette Stone; Steven Schichman; Jaclyn Garza Grenier; Dana Fein-Schaffer; Bertrand R Huber; Carmela R Abraham; Mark W Miller; Mark W Logue Journal: Neuropsychopharmacology Date: 2020-10-23 Impact factor: 7.853